LNP3794 / Boehringer Ingelheim 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LNP3794 / Boehringer Ingelheim
NCT05187858: A Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors

Completed
1
15
Europe
LNP3794
Lupin Ltd.
NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors
02/22
06/22

Download Options